MedPath

BAXTER HEALTHCARE (ASIA) PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

69

HSA:69

Drug Approvals

BAXTER PROPOFOL MCT-LCT EMULSION FOR INJECTION OR INFUSION 1% W/V

Approval Date
Jul 19, 2024
HSA

OLIMEL N7E Emulsion for Infusion

Approval Date
Oct 20, 2023
HSA

OLIMEL N9E Emulsion for Infusion

Approval Date
Oct 20, 2023
HSA

PERIOLIMEL N4E Emulsion for Infusion

Approval Date
Oct 20, 2023
HSA

BAXTER-LACTATED RINGER’S INJECTION USP

Approval Date
Sep 14, 2022
HSA

BAXTER-SODIUM CHLORIDE INJECTION USP 0.9% W/V

Approval Date
Sep 14, 2022
HSA

PHOXILIUM 1.2 MMOL/L PHOSPHATE SOLUTION FOR HAEMODIALYSIS/HAEMOFILTRATION

Approval Date
Jun 27, 2019
HSA

BIPHOZYL SOLUTION FOR HAEMODIALYSIS / HAEMOFILTRATION

Approval Date
Jul 20, 2018
HSA

REGIOCIT SOLUTION FOR HAEMOFILTRATION

Approval Date
Jul 19, 2018
HSA

MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML

Approval Date
Feb 8, 2018
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.